Manufacturing & Packaging

The CDMO’s GMP plant will dedicate 2,500 square feet to the storage of finished products.

Parties will provide processing and packaging machinery services.

Blue Fin Group exec speaks on his upcoming feature.

R&D teams need to accelerate how they conduct their research, get to a material, and get to market.

Determination will affect future vaccine cost and accessibility, including in developing countries.

MarketsandMarkets report points to growth of over $3 billion over the next five years.

How setting action-based goals and cultivating partnerships will help overcome challenges associated with implementing a sustainable GHG strategy.

Parties will establish a Center of Excellence in CMIC’s NJ plant.

Northern Ireland hub undergoes $85 million expansion.

CDMO predicts that its facilities can now potentially produce over $400 million in annual revenue.

CDMO’s goal is to increase building’s aseptic manufacturing capacity.

CDMO will financially commit $10.6 million toward semi-solid and non-sterile liquid production.

CDMO’s Heidelberg facility will house the newly-completed manufacturing line.

The report also references a CAGR of 7.8% through that year.

Packaging manufacturers partner up in effort to help tackle pharma’s demand for recyclable packaging.

Site aims to advance regenerative medicines on a global scale.

The conference will focus on the full breadth of commercialization strategies and operations.

Purchase allows company to provide a fully integrated small-to-medium scale sterile injectable service offering for the biopharma industry.

Manufacturing capacity of company’s High Point facility now doubles as a result.

The trend is continuing for brands and even for some specialty products.

CTDMO is reportedly the first to provide this aforementioned service, which spans through commercialization.

Cold chain packaging and logistics provider expands GDP-compliant bonded warehousing services.

Plant will handle end-to-end services in effort to accelerate project time.

Two months after tornado strikes North Carolina facility, manufacturing will undergo a phased approach, with full capacity expected by the end of 2023.

CDMO purchases branded sachet-packaging machine for commercial manufacturing.

The insulated shipping containers can be used in the pharma industry and are reportedly environmentally friendly.

Deal to focus on development and commercialization in key emerging countries.

Deal aims to provide diabetes treatment to patients across the continent.

SaaS’ branded platform expected to help grow manufacturer’s therapeutic development processes.

CDMO will continue to produce commercial antibody cancer drug substance, featuring a new $242 million agreement.